Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for food, industrial, nutrition and health markets, and a pioneer of plant proteins, has announced the appointment of Pierre Courduroux as its new CEO, effective December 14. Pierre Courduroux is currently the Chief Financial Officer (CFO) of Roquette, a position he took in October 2020. He has an extensive international experience, and was most recently the CFO of Monsanto, a leading global agricultural seed and biotechnology company with revenues in excess of $14B and a Market Capitalization of more than $50B.
During his long and successful career, Pierre Courduroux, a French citizen, has held leadership positions in France, Belgium, Switzerland and the USA. In these roles, he drove significant improvements in areas such as risk management, capital allocation and growth projects, while leading the Finance organization towards a model that leveraged shared services and global IT systems.
Pierre Courduroux holds an MSc in Management from the EMLyon Business School, and an Executive MBA from the Washington University in St Louis, MO, USA. Announcing the appointment, Roquette Chairman Edouard Roquette said, “Pierre is an exceptional leader. His track record is extraordinary, and we are convinced that he will build on our successful 87-year history to keep writing our bright future. He was chosen in a competitive selection process from a strong field of candidates, and he is a highly impressive talent, who represents very well our values: Authenticity, Well-Being, Forward Looking and Excellence.” Outgoing CEO Jean-Marc Gilson will become the CEO of Mitsubishi Chemical Holdings Corporation on April 1, 2021.
“I am pleased and honoured to take the position of CEO of Roquette,” said Pierre Courduroux. “In this position, I am committed to creating even more value for our employees, shareholders, customers and society at large. I am excited about the opportunity for Roquette to fulfil its mission of imagining and offering plant-based ingredients to better cure and feed people. Our drive for innovation and our long-term vision as a family company will continue to be key to achieve our objective of improving the well-being of millions of people around the world while taking care of our planet.”
RELATED NEWS
